101 related articles for article (PubMed ID: 157872)
1. The effect of streptozotocin on the pancreatic A cell function.
Kazumi T; Yoshino G; Morita S; Baba S
Endocrinol Jpn; 1979 Jun; 26(3):331-5. PubMed ID: 157872
[No Abstract] [Full Text] [Related]
2. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets.
Yamamoto H; Uchigata Y; Okamoto H
Nature; 1981 Nov; 294(5838):284-6. PubMed ID: 6272129
[No Abstract] [Full Text] [Related]
3. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets.
Yamamoto H; Okamoto H
Biochem Biophys Res Commun; 1980 Jul; 95(1):474-81. PubMed ID: 6251809
[No Abstract] [Full Text] [Related]
4. Streptozotocin-induced suppression of FAD-linked glycerophosphate dehydrogenase in pancreatic islets of adult rats.
Rasschaert J; Malaisse WJ
Biochem Int; 1991 Mar; 23(4):707-14. PubMed ID: 1831360
[TBL] [Abstract][Full Text] [Related]
5. Glucagon release from isolated pancreas in streptozotocin-treated rats.
Buchanan KD; Mawhinney WA
Diabetes; 1973 Nov; 22(11):797-800. PubMed ID: 4270690
[No Abstract] [Full Text] [Related]
6. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
Uchigata Y; Yamamoto H; Kawamura A; Okamoto H
J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Doi K
Nihon Naibunpi Gakkai Zasshi; 1975 Mar; 51(3):129-47. PubMed ID: 169168
[TBL] [Abstract][Full Text] [Related]
8. Morphometric analysis of the endocrine cell composition of rat pancreas following treatment with streptozotocin and nicotinamide.
Michels JE; Bauer GE; Johnson D; Dixit PK
Exp Mol Pathol; 1986 Jun; 44(3):247-58. PubMed ID: 3013674
[TBL] [Abstract][Full Text] [Related]
9. The characterization of the protection by nicotinamide against the action of diabetogenic nitrosoureas.
Akpan JO
Diabete Metab; 1988 Dec; 14(6):693-9. PubMed ID: 2977592
[TBL] [Abstract][Full Text] [Related]
10. Blood glucose and the histology of the pancreatic islets of Heteropneustes fossilis (Bl.) treated with streptozotocin.
Khanna SS; Rekhari K
Acta Anat (Basel); 1973; 85(1):63-8. PubMed ID: 4268273
[No Abstract] [Full Text] [Related]
11. Protection by nicotinamide against streptozotocin-induced reduction in pancreatic TRH.
Kazumi T; Utsumi M; Hirose Y; Ishihara K; Makimura H; Ejiri K; Taniguchi H; Baba S
Acta Endocrinol (Copenh); 1982 Dec; 101(4):570-3. PubMed ID: 6218725
[TBL] [Abstract][Full Text] [Related]
12. N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets.
Bedoya FJ; Solano F; Lucas M
Experientia; 1996 Apr; 52(4):344-7. PubMed ID: 8620938
[TBL] [Abstract][Full Text] [Related]
13. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
[TBL] [Abstract][Full Text] [Related]
14. Effects of streptozotocin in vitro on proinsulin biosynthesis, insulin release and ATP content of isolated rat islets of Langerhans.
Maldonato A; Trueheart PA; Renold AE; Sharp GW
Diabetologia; 1976 Oct; 12(5):471-81. PubMed ID: 135704
[TBL] [Abstract][Full Text] [Related]
15. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide.
Masiello P; Broca C; Gross R; Roye M; Manteghetti M; Hillaire-Buys D; Novelli M; Ribes G
Diabetes; 1998 Feb; 47(2):224-9. PubMed ID: 9519717
[TBL] [Abstract][Full Text] [Related]
16. Streptozotocin treated bullfrogs fail to develop insulin deficiency.
Kerns KC; Farrar ES
Comp Biochem Physiol A Comp Physiol; 1986; 85(4):765-9. PubMed ID: 2879680
[TBL] [Abstract][Full Text] [Related]
17. Biochemical studies on rats with insulin-secreting islet cell tumors induced by streptozotocin: with special reference to physiological response to oral glucose load in the course of and after tumor induction.
Kazumi T; Yoshino G; Yoshida Y; Doi K; Yoshida M; Kaneko S; Baba S
Endocrinology; 1978 Nov; 103(5):1541-5. PubMed ID: 218781
[TBL] [Abstract][Full Text] [Related]
18. Effect of streptozotocin and nicotinamide upon FAD-glycerophosphate dehydrogenase activity and insulin release in purified pancreatic B-cells.
Rasschaert J; Ling Z; Malaisse WJ
Mol Cell Biochem; 1993 Mar; 120(2):135-40. PubMed ID: 8487753
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
Masiello P; Cubeddu TL; Frosina G; Bergamini E
Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
[TBL] [Abstract][Full Text] [Related]
20. [The effect of ionizing radiation on the resistance of rat pancreatic beta cells to streptozotocin].
Gatsko GG; Brilevskaia SI
Radiobiologiia; 1993; 33(2):225-8. PubMed ID: 8502739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
